Becker K
Lerin Drug Co Inc, NY-10025
Tanzania
Review Article
An Emerging Treatment Alternative for Anemia in CKD Patients: A Review on Daprodustat
Author(s): Becker K and Jones JJBecker K and Jones JJ
This review article informs the reader about daprodustat (GSK1278863), a novel oral therapeutic agent for the treatment of anemia currently in development by GlaxoSmithKline, inclusive of published and ongoing clinical trial information. Results from phase II studies have demonstrated a promising therapeutic alternative for chronic kidney disease (CKD) patients that may ultimately change future clinical practice.
.. View More»
